• Contact Us
  • Indexing
  • Submit Manuscript
  • Open Access
  • Journals
  • Home
  • ISSN: 2373-9282
    Early Online
    Volume 6, Issue 4
    Short Communication
    Testuri M, Daghero H, Rey G, Acosta G, Bernachin J, and Marco M*
    Ovarian cancer is one of the most malignant genital cancers, with a high mortality rate. Despite decades of research, the survival rate of ovarian cancer patients is largely unchanged, and there is a pressing need for identifying novel therapeutic targets.
    Many researchers have suggested that soluble matrix metalloproteinases (MMPs) have remarkably high expression in ovarian cancer tissues, and they are considered to be related to the occurrence, development, invasion and metastasis of ovarian cancer. Moreover, some studies have discovered that the unbalance between MMPs and tissue inhibitor of metalloproteinases (TIMPs) are associated with the malignant phenotype of tumors. In spite of this, there is a lack of information about the expression of membrane type –MMPs (without taking into account MT1-MMP) in ovarian cancer.
    This report shows (using immunohistochemistry) an increase in the expression of MT3- and MT5-MMPs especially in the most aggressive histological types (comparing with normal and benign tumors), which could suggest a possible biological role in the development of this pathology.
    Short Note
    Parthasarathy Sonaimuthu*
    My research interest focuses on infectious diseases involving protozoan parasites such as Toxoplasma gondii and Plasmodium falciparum that are the reason for infections classified as neglected tropical diseases. The parasitic diseases are one of the reasons for majorsignificant global economic, environmental, and public health impacts.
    Research Article
    Mitiku Bajiro*, Shewatateck Gedamu, Niguse Hamba, and YonasAlemu
    Background: Intestinal Schistosomiasis and Soil transmitted helminthes infections are among the major public health problems especially in Sub-Saharan African countries including Ethiopia. However, little is known about the distribution of these infections in area where there is risk factors for infection, especially schools at nearby rivers. Therefore objective of this study is to determine the prevalence, infection intensity and associated risk factors among two primary school children at nearby rivers of Jimma town.
    Methods: A cross-sectional study was conducted among two primary school children aged from 6 to 19 years in Jimma town from March to April/15 2016. For diagnosis of Schistosoma mansoni (S. mansoni) and soil transmitted helminthes (STHs), a single stool sample was obtained from each child and processed using single Kato Katz and examined using light microscope. A questionnaire was used to collect demographic information of the school children participated in the study and variables used for risk factors assessments. Data were analyzed using SPSS version 20.0 and variables with P-value < 0.05 were considered as significantly associated with S. mansoni and STHs infections.
    Results: The overall prevalence of intestinal helminthes infection with S. mansoni and STHs was 50.64 %( 118/233). The prevalence of S. mansoni among school children of the two primary schools was 26.6 %( 62/233) with the prevalence of 29.2% in males and 23.3% in females. The prevalence of T. trichuira, A. lumbricoides and hookworms among the school children in Jimma town was 22.3%, 20.2% and 3.4% respectively. Majority of the infection intensity for both S. mansoni and STHs were classified as low.
    Water contact habits has significantly associated with S. mansoni infection where as finger trimming status, frequency of handing washing habit before meal and after toilet were significantly associated with, A. lumbricoides and T. trichuira infections (P < 0.05).
    Conclusion: The prevalence of intestinal helminthes infection with S. mansoni and STHs were 50.64 %; with the prevalence of S. mansoni, T. trichuira, A. lumbricoides and hookworms were 26.6%, 22.3%, 20.2% and 3.4% among the school children in the two schools. Majority of the infection intensity for both S. mansoni and STHs were classified as low. The school children were at moderate risk of infection with S. mansoni and STHs based on WHO 2012 prevalence classification in which once a year MDA is required for STHs and biannual MDA for S. mansoni. Health information regarding the transmission and prevention of S. mansoni and STHs should be given for school age children in the area.
    Case Report
    Manouchehr Aghajanzadeh, Cyrus Emir Alavi, Siamak Rimaz, Fereshteh Mohamadi, Siamak Geranmayeh, and Zakiyeh Jafaryparvar*
    Thymic Neuroendocrine Tumor (TNET) is rare and its incidence rate is approximately 2–5%. Carcinoid tumor of thymus with Cushing’s syndrome (CS) is a rare co-morbid condition. We report a 19-year-old girl with CS who had8-months history of 10-15 kg weight gain, acne on face and back of the hands, menstrual irregularity, depression, fatigue and fatigability, moon faces, buffalo hump, truncal obesity and cutaneous striae. Initial laboratory tests revealed a serum cortisol level of 78 µg/DL, morning serum cortisol of 130 µg/DL, the ACTH level of 440 pg/ml and a 24 hour urinary free cortisol level of 11000µg/24 hours. Thorax computed tomography showed a heterogeneous well defined mass measuring about 18×15 mm in the anterior compartment of the mediastinum. An extended thymectomy was performed by a median sternotomy. Report of pathologist was “Well-differentiated neuroendocrine neoplasm (Typical carcinoid tumor of thymus, grade 1) without lymphatic and vascular invasion”.
  • Recent Articles
  • JSciMed Central welcomes back astronaut Scott Kelly and cosmonaut Mikhail Kornienko.
    Readmore...

    Wonder Women Tech not only disrupted the traditional conference model but innovatively changed the way conferences should be held.
    Readmore...

    JSciMed Central Peer-reviewed Open Access Journals
    10120 S Eastern Ave, Henderson,
    Nevada 89052, USA
    Tel: (702)-751-7806
    Toll free number: 1-800-762-9856
    Fax: (844)-572-4633 (844-JSCIMED)
    E-mail: pathology@jscimedcentral.com
    1455 Frazee Road, Suite 570
    San Diego, California 92108, USA
    Tel: (619)-373-8720
    Toll free number: 1-800-762-9856
    Fax: (844)-572-4633 (844-JSCIMED)
    E-mail: pathology@jscimedcentral.com
    About      |      Journals      |      Open Access      |      Special Issue Proposals      |      Guidelines      |      Submit Manuscript      |      Contacts
    Copyright © 2016 JSciMed Central All Rights Reserved
    Creative Commons Licence Open Access Publication by JSciMed Central is licensed under a Creative Commons Attribution 4.0 International License.
    Based on a work at https://jscimedcentral.com/. Permissions beyond the scope of this license may be available at https://creativecommons.org/.